Literature DB >> 21327435

Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies.

Esra Ozcan1, Ozlem Yilmaz, Ahmet Tutoglu, Hatice Bodur.   

Abstract

The Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) was built by adding five new questions related with cervical and lumbar spine functions to HAQ by Daltroy et al. (in J Rheumatol 17(7):946-945, 1990). The aim of this study was to adapt the added five items into Turkish and then to test its reliability and validity. New questions were adapted to Turkish according to 'translation-back translation' method. Seventy-nine patients with ankylosing spondylitis were asked with the Turkish version of HAQ-S (HAQ-S TV). To assess, construct validity patients were evaluated by HAQ, Bath AS Functional Index (BASFI), Bath AS Disease Activity Index (BASDAI), Bath AS Metrology Index (BASMI), Maastricht AS Enthesitis Score (MASES), Ankylosing Spondylitis Quality of Life (ASQoL), and laboratory variables (erythrocyte sedimentation rate, C-reactive protein). Construct validity was investigated with Spearmann's rank correlation coefficient. Reliability of HAQ-S TV was assessed by internal consistency. Inter- and intra-observer reliability were tested with Cronbach's alpha score. HAQ-S TV met set criteria of reliability and validity. Reliability of adapted version was found good with high internal consistency value. (Cronbach's alpha = 0.89). In addition to this intra-observer and inter-observer reliability were found adequate for total score of HAQ-S (Cronbach's alphas: 0.999 and 0.998 in order) and also for each added five questions (Cronbach's alphas >0.7). Positive correlations were found between HAQ-S TV and HAQ, BASFI, BASDAI, BASMI, MASES, ASQoL, ESR, and CRP (P < 0.05). The results of this study showed that HAQ-S TV was reliable and valid in patients with AS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327435     DOI: 10.1007/s00296-011-1795-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire.

Authors:  Ayse A Küçükdeveci; Hülya Sahin; Sebnem Ataman; Bridget Griffiths; Alan Tennant
Journal:  Arthritis Rheum       Date:  2004-02-15

3.  Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation.

Authors:  Samuel Katsuyuki Shinjo; Roberta Gonçalves; Sérgio Kowalski; Célio Roberto Gonçalves
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 2.980

Review 4.  A psychometric toolbox for testing validity and reliability.

Authors:  Holli A DeVon; Michelle E Block; Patricia Moyle-Wright; Diane M Ernst; Susan J Hayden; Deborah J Lazzara; Suzanne M Savoy; Elizabeth Kostas-Polston
Journal:  J Nurs Scholarsh       Date:  2007       Impact factor: 3.176

Review 5.  Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials.

Authors:  Catherine Acquadro; Katrin Conway; Asha Hareendran; Neil Aaronson
Journal:  Value Health       Date:  2007-12-18       Impact factor: 5.725

Review 6.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

7.  A modification of the Health Assessment Questionnaire for the spondyloarthropathies.

Authors:  L H Daltroy; M G Larson; N W Roberts; M H Liang
Journal:  J Rheumatol       Date:  1990-07       Impact factor: 4.666

8.  Functional changes in patients with spondylarthropathy. A controlled trial of the effects of short-term rehabilitation and 3-year follow-up.

Authors:  J V Viitanen; S Heikkilä
Journal:  Rheumatol Int       Date:  2001-07       Impact factor: 2.631

9.  Validity and sensitivity to change of spondylitis-specific measures of functional disability.

Authors:  M M Ward; S Kuzis
Journal:  J Rheumatol       Date:  1999-01       Impact factor: 4.666

10.  Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population.

Authors:  L K Zhao; Z T Liao; C H Li; T W Li; J Wu; Q Lin; F Huang; D T Yu; J R Gu
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 3.580

View more
  3 in total

1.  Cross-cultural adaptation and validation of the Chinese version of the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S).

Authors:  DeLin Liu; Chen Zhang; Chen Wang; Jiao Liu; DaHe Li; Jia Li; Weidong Xu
Journal:  Clin Rheumatol       Date:  2017-07-27       Impact factor: 2.980

2.  Evaluation of the Psychometric Properties of the Health Assessment Questionnaire (HAQ) in a Population of Individuals With Multiple Sclerosis.

Authors:  Anna Berardi; Antonella Conte; Lucilla Cimmino; Carlotta Cimmino; Viola Baione; Sebastiano Giuseppe Crisafulli; Marco Tofani; Matteo Tartaglia; Giovanni Fabbrini; Giovanni Galeoto
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.003

3.  Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs.

Authors:  Yaşar Keskin; Kemal Nas; Erkan Kiliç; Betul Sargin; Sevtap Acer Kasman; Hakan Alkan; Nilay Şahin; Gizem Cengiz; Nihan Cuzdan; İlknur Albayrak Gezer; Dilek Keskin; Cevriye Mülkoğlu; Hatice Resorlu; Şebnem Ataman; Ajda Bal; Mehmet Tuncay Duruoz; Okan Küçükakkas; Ozan Volkan Yurdakul; Meltem Alkan Melikoğlu; Yıldıray Aydin; F Figen Ayhan; Hatice Bodur; Mustafa Çaliş; Erhan Çapkin; Gül Devrimsel; Kevser Gök; Sami Hizmetli; Ayhan Kamanli; Hilal Ecesoy; Öznur Kutluk; Nesrin Şen; Ömer Faruk Şendur; İbrahim Tekeoğlu; Sena Tolu; Murat Toprak; Tiraje Tuncer
Journal:  Arch Rheumatol       Date:  2020-07-01       Impact factor: 1.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.